Knowles (KN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Q1 2025 revenue reached $132.2 million, at the high end of guidance, with non-GAAP diluted EPS of $0.18 at the midpoint of guidance and strong cash from operations exceeding guidance.
Net cash from operations was $1.3 million, supporting $5 million in share repurchases and $15 million in debt reduction.
Minimal direct (less than 5%) and indirect (less than 3%) tariff exposure, with most impacts expected to be recoverable through pricing.
Strong backlog and order activity in medtech, defense, and industrial markets, with normalized distributor inventory levels.
Sale of Consumer MEMS Microphones business completed; results reclassified as discontinued operations.
Financial highlights
Q1 2025 revenue was $132.2 million, down 1% year-over-year but at the high end of guidance.
Non-GAAP gross margin was 41.6%, up from 39.9% in Q1 2024 but down from 43.4% year-over-year.
Adjusted EBITDA was $26.7 million (20.2% margin), compared to $28.5 million (21.4%) last year.
Adjusted free cash flow was $18.3 million (13.8% of revenue), up from $13.3 million (10.0%) year-over-year.
Exited Q1 with $101.9 million in cash and $119 million in long-term debt; net leverage ratio at 0.7x trailing 12-month adjusted EBITDA.
Outlook and guidance
Q2 2025 revenue expected between $135–$145 million, representing 4% year-over-year and 6% sequential growth at the midpoint.
Q2 non-GAAP diluted EPS projected at $0.21–$0.25; adjusted EBIT margin expected at 19–21%.
Net cash from operations for Q2 2025 expected between $10–$20 million.
Full-year capital spending to be 4–6% of revenues, focused on specialty film line expansion.
Gross margin expected to exit 2025 in the 45–47% range.
Latest events from Knowles
- Q4 and full year 2025 results exceeded guidance, with strong growth and positive 2026 outlook.KN
Q4 20258 Jul 2026 - Q3 revenue up 32% year-over-year; strategic divestiture and margin gains position for growth.KN
Q3 20248 Jul 2026 - Transformation drives strong growth, margin expansion, and new opportunities in resilient markets.KN
16th Annual East Coast IDEAS Conference12 Jun 2026 - Q1 2026 revenue rose 16% to $153.1M, with 50% EPS growth and strong segment margins.KN
Q1 202628 Apr 2026 - Annual meeting covers director elections, executive pay, and auditor ratification for 2026.KN
Proxy Filing11 Mar 2026 - 2026 proxy covers director elections, executive pay, auditor ratification, and robust governance.KN
Proxy Filing11 Mar 2026 - Portfolio shift to MedTech, defense, and industrial boosts margins and growth outlook.KN
2024 Southwest IDEAS Conference3 Feb 2026 - Targets 8–10% annual revenue growth and 10–14% EBITDA growth through organic and M&A strategies.KN
Investor Day 20253 Feb 2026 - Q2 revenue up 18.3% to $204.7M; $249.4M goodwill impairment drove $259M net loss.KN
Q2 20242 Feb 2026